Navigation Links
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
Date:4/27/2012

Munich, Germany, April 27th, 2012 - Genomatix is proud to announce that it has been awarded the "INDUSTRIEPREIS 2012" in the biotech category at Hannover Messe, the world's biggest technology trade show. The INDUSTRIEPREIS is awarded in 14 categories to companies for products of a high technological, economic, ecological or social value. Nominees and winners are chosen by a panel of 30 experts including professors and specialized journalists. Genomatix has received the INDUSTRIEPREIS for its data analysis and interpretation platform Genomatix Genome Analyzer (GGA).

"We're really proud to have received this award for a data analysis solution", says Dr. Korbinian Grote, product manager at Genomatix. "Usually the focus on big technology fairs is more on lab equipment providers, in our field the sequencer manufacturers stand out with ever new records of gigabases of DNA data they can produce. But researchers also need solutions to analyze and interpret these data to extract the information from it and generate new biomedical knowledge." "Being appreciated for our data analysis solutions is certainly a big motivation for the whole team to come up with even more innovative ideas on how to deal with the increasing deluge of Next Generation Sequencing data", adds Dr. Martin Seifert, CEO of Genomatix, "getting an award that explicitly rewards products of technological and social value underlines that NGS is quickly moving from a research tool into the broader field of clinical application."


'/>"/>
Contact: Korbinian Grote
grote@genomatix.de
0049-599-7660
Genomatix Software GmbH
Source:Eurekalert  

Page: 1

Related biology news :

1. Genomatix to partner in $41 million European epigenomics consortium
2. Genomatix wins "Most Creative Visualization" award at iDEA Challenge 2011
3. Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS
4. Eurofins MWG Operon and Genomatix developed most complete human exome array
5. Eurofins MWG Operon and Genomatix launch strategic alliance
6. Genomatix gives a hand in the analysis of Wayne States sequencing projects
7. University of Michigan installs second Genomatix Genome Analyzer
8. MCTP bought Genomatix NextGen Sequencing analysis stations
9. Genomatix gets patent for comparative genomics method
10. CRG buys Genomatix Next Generation Sequencing analysis solution
11. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... ... May 05, 2016 , ... CereScan, the nation’s ... Stroke Association during National Stroke Awareness Month in May. An infographic created ... the month. CereScan will donate $1 up to a maximum of $3,000 ...
(Date:5/4/2016)... Diego, CA (PRWEB) , ... May 04, 2016 ... ... Day? Well, look no further than LaJollaCooks4u, San Diego’s premiere hands-on cooking experience. ... you need to give mom an experience she won’t forget. , Guests that ...
(Date:5/4/2016)... ... , ... Proove Biosciences, Inc. , the commercial and research leader in ... . The partnership is designed to advance research in pain genetics in an effort ... With the new agreement, researchers at Proove Biosciences are able to collaborate with Luda ...
(Date:5/4/2016)...  Bayer today announced that a Phase III ... (regorafenib) tablets for the treatment of patients with ... endpoint of a statistically significant improvement in overall ... and safety of regorafenib in patients with HCC ... The safety and tolerability were generally consistent with ...
Breaking Biology Technology: